Fat Loss & Metabolic Health

AOD-9604 Dosage Chart: Reconstitution & mg-to-Units for Research

The dominant research question behind the phrase aod 9604 dosage is not “how much should a person take” — it is a…

Cagrilintide Titration: Week-by-Week Schedule (2026)

A researcher holding a 5 mg or 10 mg cagrilintide vial faces a deceptively simple question: how many milligrams per week, and how many…

MOTS-c Dosage: Chart, Amount Per Day & the Complete Protocol

The MOTS-c dose repeated across vendor pages, forum threads and protocol PDFs is roughly 200 mcg per day, five days a week, subcutaneously.…

What Is Survodutide? The GLP-1/Glucagon Dual Agonist Explained for Research

Survodutide (BI 456906) is a once-weekly injectable peptide that activates two hormone receptors at once — GLP-1 and glucagon — and it…

Tirzepatide and Liver Fat: Results, Timeline and Liver Safety

Tirzepatide removes a large amount of liver fat, and the human data behind that claim is unusually strong. In the SURPASS-3 MRI…

What Are Research Insights on Retatrutide for Neuroendocrine Appetite Dysregulation in Binge Eating Disorder?

The research question at the center of this article is narrow and worth stating plainly: what do the current data allow researchers…

Is Cagrilintide a Promising Investigational Approach for Reducing Prediabetes Risk?

No trial has ever tested cagrilintide in prediabetes, so the honest answer is that nobody knows yet. What does exist is indirect…

What Is Orforglipron? The Oral GLP-1 Pill Explained for Research

Orforglipron (developmental code LY3502970, brand name Foundayo) is the first orally administered, small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist to reach late-stage development…

Orforglipron vs Semaglutide vs Tirzepatide: Oral GLP-1 in Research

For more than a decade the entire incretin class shared one inconvenient trait: it lived inside a needle. Semaglutide, tirzepatide, and the…

Does Semaglutide Play a Role in Nonalcoholic Fatty Liver Disease Research?

Few peptides have moved from metabolic research into hepatology as rapidly as semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist whose weight-lowering…